DONGGUAN XINLAN ELECTRONIC TECHNOLOGY CO., LTD. – Trademark Portfolio

Entity Type: 11

DONGGUAN XINLAN ELECTRONIC TECHNOLOGY CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include CALBIN. The owner is based in DONGGUAN.

ROOM 1202,UNIT 4,NO. 10 HONGFENG

RD,CHANG'AN, TOWN

DONGGUAN , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CALBIN
CALBIN
Registered 2020

Trademark Classifications

DONGGUAN XINLAN ELECTRONIC TECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does DONGGUAN XINLAN ELECTRONIC TECHNOLOGY CO., LTD. have?

DONGGUAN XINLAN ELECTRONIC TECHNOLOGY CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does DONGGUAN XINLAN ELECTRONIC TECHNOLOGY CO., LTD. file in?

DONGGUAN XINLAN ELECTRONIC TECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are DONGGUAN XINLAN ELECTRONIC TECHNOLOGY CO., LTD.'s most well-known trademarks?

DONGGUAN XINLAN ELECTRONIC TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as CALBIN. These are among 1 currently registered trademark in the portfolio.

What is DONGGUAN XINLAN ELECTRONIC TECHNOLOGY CO., LTD.'s trademark registration success rate?

DONGGUAN XINLAN ELECTRONIC TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.